首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1547892

全球自然殺手細胞治療市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Natural Killer Cells Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球自然殺手細胞治療市場的需求預計將從2023年的30.6億美元達到2032年近125.9億美元的市場規模，2024-2032年研究期間的複合年成長率為17.02%。

自然殺手細胞療法是醫學界快速成長的市場。它們是一組能夠快速回應病理挑戰的顆粒淋巴細胞。它們還負責在我們的體內產生免疫調節細胞因子，這是消除任何病理挑戰所必需的。它們是人體先天免疫系統所需的重要助推器。此外，它們還幫助身體做好針對病原體快速反應的準備。

市場動態

更多的資源被用於開發先進療法，包括自然殺手細胞，因為它們對於預防和治療傳染病以及消除感染者體內的癌細胞非常有用。自然殺手細胞治療市場的主要驅動力是癌症和肝病治療市場，該技術在這些市場中已廣泛應用。冠狀病毒的爆發使人們更加了解可以增強免疫系統的療法，這對市場起到了重大推動作用。市場面臨的主要限制是高成本和低特異性。此外，這些培養物的生存機會很低，並且需要一些時間才能生長，這對市場來說是一個挑戰。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球自然殺手細胞治療市場的每個細分市場進行了包容性評估。自然殺手細胞治療產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

自然殺手細胞治療市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

透過治療分析

NK 細胞定向抗體
NK 細胞療法

按應用分析

免疫增生性疾病
胃腸道疾病
癌症
其他應用

透過最終用戶分析

醫院
研究中心和研究所
其他最終用戶

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲自然殺手細胞治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。自然殺手細胞治療市場的主要參與者包括 NKT Therapeutics Inc.、Nkarta Therapeutics Inc.、Nantkwest Inc.、Innate Pharma SA、Glycostem Therapeutics BV、Fortress Biotech、Fate Therapeutics、Celgene Corporation、Affimed NV 和 Ziopharm Oncology Inc.。的。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：自然殺手細胞治療公司的競爭格局

自然殺手細胞治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
NKT Therapeutics Inc.

公司概況
公司收入
產品
最新動態

Nkarta Therapeutics Inc.

公司概況
公司收入
產品
最新動態

Nantkwest Inc.

公司概況
公司收入
產品
最新動態

Innate Pharma SA

公司概況
公司收入
產品
最新動態

Glycostem Therapeutics BV

公司概況
公司收入
產品
最新動態

Fortress Biotech

公司概況
公司收入
產品
最新動態

Fate Therapeutics

公司概況
公司收入
產品
最新動態

Celgene Corporation

公司概況
公司收入
產品
最新動態

Affimed NV And Ziopharm Oncology Inc.

公司概況
公司收入
產品
最新動態

其他
- 公司概況
- 公司收入
- 產品
- 最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11212583

The global demand for Natural Killer Cells Therapeutics Market is presumed to reach the market size of nearly USD 12.59 Billion by 2032 from USD 3.06 Billion in 2023 with a CAGR of 17.02% under the study period 2024-2032.

Natural killer cell therapeutics is a rapidly rising market in the medical world. They are a group of granular lymphocytes that can quickly respond to a pathological challenge. They are also responsible for producing immunoregulatory cytokines in our body, which are necessary for eliminating any kind of pathological challenge. They are the vital booster needed for the innate immune system of the human body. Also, they prepare the body for a quick response against a pathogen.

MARKET DYNAMICS

More resources are being used behind the development of advanced therapies, including natural killer cells, as they are extremely useful for preventing and curing infectious diseases and also for eliminating cancer cells from an infected person. The major driver for the natural killer cells therapeutics market is the market for cancer and liver disease treatment, where this technique is widely used. The coronavirus outbreak has caused people to be more aware of the therapies that can strengthen their immune systems, and it has acted as a major boost for the market. The major restraint being faced by the market is in the form of high costs and low specificity. Also, the cultures have low chances of survival and take some time to grow, which is a challenge for the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Natural Killer Cells Therapeutics. The growth and trends of Natural Killer Cells Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Natural Killer Cells Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapeutics Analysis

NK Cell Directed Antibodies
NK Cell Therapies

By Application Analysis

Immunoproliferative Disorders
Gastrointestinal Diseases
Cancer
Other Applications

By End User Analysis

Hospitals
Research Centers & Institutes
Other End Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Natural Killer Cells Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Natural Killer Cells Therapeutics market include NKT Therapeutics Inc., Nkarta Therapeutics Inc., Nantkwest Inc., Innate Pharma S.A., Glycostem Therapeutics BV, Fortress Biotech, Fate Therapeutics, Celgene Corporation, Affimed N.V. And Ziopharm Oncology Inc., Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. NATURAL KILLER CELLS THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Therapeutics Analysis
- 3.7.2 Market Attractiveness Analysis By Application Analysis
- 3.7.3 Market Attractiveness Analysis By End User Analysis
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY THERAPEUTICS ANALYSIS

5.1. Overview By Therapeutics Analysis
5.2. Historical and Forecast Data
5.3. Analysis By Therapeutics Analysis
5.4. NK Cell Directed Antibodies Historic and Forecast Sales By Regions
5.5. NK Cell Therapies Historic and Forecast Sales By Regions

6. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY APPLICATION ANALYSIS

6.1. Overview By Application Analysis
6.2. Historical and Forecast Data
6.3. Analysis By Application Analysis
6.4. Immunoproliferative Disorders Historic and Forecast Sales By Regions
6.5. Gastrointestinal Diseases Historic and Forecast Sales By Regions
6.6. Cancer Historic and Forecast Sales By Regions
6.7. Other Applications Historic and Forecast Sales By Regions

7. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY END USER ANALYSIS

7.1. Overview By End User Analysis
7.2. Historical and Forecast Data
7.3. Analysis By End User Analysis
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Research Centers & Institutes Historic and Forecast Sales By Regions
7.6. Other End Users Historic and Forecast Sales By Regions

8. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE NATURAL KILLER CELLS THERAPEUTICS COMPANIES

9.1. Natural Killer Cells Therapeutics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF NATURAL KILLER CELLS THERAPEUTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. NKT Therapeutics Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Nkarta Therapeutics Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Nantkwest Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Innate Pharma S.A.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Glycostem Therapeutics BV
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Fortress Biotech
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Fate Therapeutics
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Celgene Corporation
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Affimed N.V. And Ziopharm Oncology Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Others
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments